The CDC published updated expanded recommendations from the Advisory Committee on Immunization Practices (ACIP) for pneumococcal conjugate vaccines (PCV) among adults aged 50 and older. These recommendations, published on January 9, 2025, in the MMWR, reflect changes made in October 2024.
Key points include:
- A single dose of PCV is now recommended for all adults aged 50 and older who are PCV-naïve or have an unknown vaccination history.
- The risk-based recommendation for adults aged 19–49 remains unchanged.
- The updated guidelines aim to improve pneumococcal disease prevention in adults aged 50–64, particularly among groups with higher disease rates.
These changes are expected to enhance vaccination coverage and reduce the incidence of pneumococcal disease in the targeted age group. Visit the CDC for more information.